Home Cart 0 Sign in  

[ CAS No. 942189-39-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 942189-39-1
Chemical Structure| 942189-39-1
Structure of 942189-39-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 942189-39-1 ]

Related Doc. of [ 942189-39-1 ]

Alternatived Products of [ 942189-39-1 ]

Product Details of [ 942189-39-1 ]

CAS No. :942189-39-1 MDL No. :MFCD17169854
Formula : C26H18BrN3O2 Boiling Point : -
Linear Structure Formula :- InChI Key :PDUHZXZECHMGLL-UHFFFAOYSA-N
M.W : 484.34 Pubchem ID :58946443
Synonyms :

Calculated chemistry of [ 942189-39-1 ]

Physicochemical Properties

Num. heavy atoms : 32
Num. arom. heavy atoms : 27
Fraction Csp3 : 0.04
Num. rotatable bonds : 5
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 130.86
TPSA : 63.64 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.14 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.62
Log Po/w (XLOGP3) : 7.2
Log Po/w (WLOGP) : 6.55
Log Po/w (MLOGP) : 5.81
Log Po/w (SILICOS-IT) : 3.82
Consensus Log Po/w : 5.4

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -7.67
Solubility : 0.0000103 mg/ml ; 0.0000000212 mol/l
Class : Poorly soluble
Log S (Ali) : -8.36
Solubility : 0.00000212 mg/ml ; 0.0000000044 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -9.76
Solubility : 0.0000000851 mg/ml ; 0.0000000002 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.54

Safety of [ 942189-39-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H320-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 942189-39-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 942189-39-1 ]
  • Downstream synthetic route of [ 942189-39-1 ]

[ 942189-39-1 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 76-83-5 ]
  • [ 5401-94-5 ]
  • [ 942189-39-1 ]
YieldReaction ConditionsOperation in experiment
10%
Stage #1: With bromine In methanol
Stage #2: With sodium hydride In N,N-dimethyl-formamide
(S)-N-(3-(6-isopropoxypyridin-3-yl)- 1H-indazol-5-yl)- 1 -(2-(4-(4-(1 -methyl-1H- 1 ,2,4-triazol-3 -yl)phenyl)-3 , 6-dihydropyridin- 1 (2H)-yl)-2-oxoethyl)-3 -(methylthio)pyrrolidine3-carboxamide free base synthesis is a 19 step process. Compound preparation is divided into three intermediate preparations A, B and C followed by coupling of the intermediates. Allintermediates start with commercially available compounds. Compound 5 is prepared by reaction of the commercially available bromo-4-cyanobenzene with methyl hydrazine under acidic conditions to form the hydrazinoimidate 2 in modest yield. After reaction with formic acid in two steps the bromophenyl-N-methyl triazole intermediate 3 is obtained. The tetrahydropyridine ring is introduced by a Suzuki reaction of the commercially available Bocprotected tetrahydropyridine-boronate to obtain the tricyclic ring system 4. Chloroacetamide 5 is obtained in excellent yield by reaction of the deprotected 4 with chloroacetylchloride. The pyrrolidine core lOa is obtained in good yield in 5 steps starting from commercially available 6. Reaction with thionylchloride gave the thiomethyl olefin 7. Cycloaddition (2+3) gives 8 followed by removal of the benzyl protection group to give 9. L-Tartaric acid resolution of thepyrrolidine core gives the pure (5) enantiomer 9 after filtration from methanol. After protection as the Boc derivative and hydrolysis of the methyl ester, 10 is obtained in overall 50percent yield. Compound 17 is obtained from commercially available indazole 11. Bromination at the 3- position of indazole 11 proceeds in excellent yield without chromatography to obtain 12. Suzuki reaction of the bromo compound 12 with 14 gives the nitro indazole 16 after chromatography.Reduction of 16 gives aniline 17 as an oil in quantitative yield without chromatography. The final coupling of the intermediates proceeded by coupling 17 with lOa to obtain 18 in good yield. After deprotection of the Boc and Trityl groups the final coupling with 5 gave (S)-N-(3-(6- isopropoxypyridin-3-yl)- 1H-indazol-5-yl)-1 -(2-(4-(4-(1 -methyl-1H- 1 ,2,4-triazol-3-yl)phenyl)- 3 ,6-dihydropyridin- 1 (2H)-yl)-2-oxoethyl)-3 -(methylthio)pyrrolidine-3 -carboxamide afterchromatography. Final purification is carried out by crystallization from methanol/diethylether.This synthetic route has been conducted on a scale that delivered (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)- 1 -(2-(4-(4-(1 -methyl-1H- 1 ,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1 (2H)-yl)-2-oxoethyl)-3 -(methylthio)pyrroli dine-3 -carboxamide free base (Compound I).
Reference: [1] Patent: WO2016/100152, 2016, A1, . Location in patent: Page/Page column 8; 10
[2] Patent: WO2016/100147, 2016, A1, . Location in patent: Page/Page column 5; 8
[3] Patent: WO2017/40362, 2017, A1, . Location in patent: Page/Page column 4; 6
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 942189-39-1 ]

Aryls

Chemical Structure| 529508-58-5

[ 529508-58-5 ]

1-(3-Fluorobenzyl)-5-nitro-1H-indazole

Similarity: 0.66

Chemical Structure| 1785580-89-3

[ 1785580-89-3 ]

3-Bromo-1-methyl-5-phenyl-1H-pyrazole

Similarity: 0.64

Chemical Structure| 88095-61-8

[ 88095-61-8 ]

1-Benzyl-4-nitro-1H-pyrazole

Similarity: 0.63

Chemical Structure| 1204355-48-5

[ 1204355-48-5 ]

1-(tert-Butyl)-5-phenyl-1H-pyrazole

Similarity: 0.63

Chemical Structure| 1700661-39-7

[ 1700661-39-7 ]

3-Bromo-4-methyl-1-phenyl-1H-pyrazole

Similarity: 0.62

Bromides

Chemical Structure| 74209-25-9

[ 74209-25-9 ]

3-Bromo-1-methyl-5-nitro-1H-indazole

Similarity: 0.77

Chemical Structure| 70315-68-3

[ 70315-68-3 ]

3-Bromo-6-nitroindazole

Similarity: 0.73

Chemical Structure| 74209-34-0

[ 74209-34-0 ]

3-Bromo-7-nitro-1H-indazole

Similarity: 0.70

Chemical Structure| 67400-25-3

[ 67400-25-3 ]

3-Bromo-5-nitroindazole

Similarity: 0.70

Chemical Structure| 1092351-49-9

[ 1092351-49-9 ]

3-Bromo-1-methyl-1H-indazol-5-amine

Similarity: 0.68

Nitroes

Chemical Structure| 74209-25-9

[ 74209-25-9 ]

3-Bromo-1-methyl-5-nitro-1H-indazole

Similarity: 0.77

Chemical Structure| 70315-68-3

[ 70315-68-3 ]

3-Bromo-6-nitroindazole

Similarity: 0.73

Chemical Structure| 5228-49-9

[ 5228-49-9 ]

1-Methyl-5-nitro-1H-indazole

Similarity: 0.70

Chemical Structure| 74209-34-0

[ 74209-34-0 ]

3-Bromo-7-nitro-1H-indazole

Similarity: 0.70

Chemical Structure| 67400-25-3

[ 67400-25-3 ]

3-Bromo-5-nitroindazole

Similarity: 0.70

Related Parent Nucleus of
[ 942189-39-1 ]

Indazoles

Chemical Structure| 74209-25-9

[ 74209-25-9 ]

3-Bromo-1-methyl-5-nitro-1H-indazole

Similarity: 0.77

Chemical Structure| 70315-68-3

[ 70315-68-3 ]

3-Bromo-6-nitroindazole

Similarity: 0.73

Chemical Structure| 5228-49-9

[ 5228-49-9 ]

1-Methyl-5-nitro-1H-indazole

Similarity: 0.70

Chemical Structure| 74209-34-0

[ 74209-34-0 ]

3-Bromo-7-nitro-1H-indazole

Similarity: 0.70

Chemical Structure| 67400-25-3

[ 67400-25-3 ]

3-Bromo-5-nitroindazole

Similarity: 0.70